Low iron saturation occurs when the amount of iron in the blood decreases below the recommended range. People may also refer to this as iron deficiency.
Iron saturation refers to the amount of iron that is present in the blood. Iron is vital for many molecular processes, including muscle metabolism, oxygen transport, and the maintenance of healthy connective tissue.
People usually obtain sufficient iron from the diet.
However, some individuals may experience low iron, which can lead to iron deficiency anemia. In those with this condition, the blood lacks adequate red blood cells due to a shortage of iron.
This article will explore what constitutes low iron saturation and what symptoms this can produce. It will also explain what may cause low iron saturation, how a medical professional will diagnose it, and what treatments are available.
A variety of tests measure the level of iron in the blood.
Doctors often test for low iron levels if hemoglobin is low and consistent with anemia.
The normal range of iron saturation can vary from person to person, and it can change over time depending on a persons health.
There are three measurements that a doctor can take to determine the level of iron in the body.
Transferrin is among the proteins that the blood contains. This protein binds to iron, which it transports around the body and to the bone marrow to produce hemoglobin. Hemoglobin is present in red blood cells.
Measuring transferrin may indicate the level of iron saturation in the blood. The normal range for transferrin is 204360 milligrams (mg) per deciliter. An amount higher than this indicates a low level of iron saturation.
TIBC indicates the total amount of iron to which protein in the blood can bind.
Measuring TIBC may also indicate the saturation level of iron. The normal range for TIBC is 250450 micrograms per deciliter (mcg/dl). A value higher than this range may indicate iron deficiency or low iron saturation.
A medical professional may also measure the serum iron level.
The serum iron test measures the level of iron in the blood. The normal range for serum iron is:
Values below these reference ranges indicate a low iron saturation.
There are different stages of iron deficiency and iron depletion. These include:
A person with a low iron saturation in the blood may experience various symptoms of iron deficiency. The most common include:
A person may have a low iron saturation level for various reasons.
Common causes of low iron saturation include:
Certain factors can increase a persons likelihood of experiencing low iron saturation. These include medical conditions and lifestyle choices, such as diet.
Examples of risk factors for low iron saturation include:
A doctor may begin the diagnostic process by carrying out a physical examination and looking for signs of low iron saturation, such as bleeding and spooning of the nails or brittle nails. They may also listen to the heart for any irregular heartbeats and feel the abdomen to check the size of the liver and spleen.
The doctor may then order blood tests to confirm a diagnosis of low iron saturation.
These tests may include:
The treatment for low iron saturation levels focuses on raising the iron saturation level so that it falls within the normal range.
A person with a low iron saturation level may need to take medicinal iron to increase their saturation level. Medicinal iron contains more iron than multivitamins. Most adults with iron deficiency require 25 mg of iron per kilogram of body weight per day.
Experts do not generally recommend iron supplements for people who do not have iron deficiency anemia, as too much iron can damage the organs.
A person can also take other vitamins that improve iron absorption, such as vitamin C.
In cases where the gastrointestinal tract has difficulty absorbing iron, the intravenous delivery of iron meaning through a blood vessel may be necessary.
People with severe iron deficiency anemia may require a red blood cell transfusion. This procedure quickly increases the number of red blood cells and iron in the blood and improves iron saturation.
A person can also make lifestyle changes to increase their iron saturation levels. These changes may include:
A low iron saturation level or iron deficiency may lead to other complications. Some of the possible complications include:
A person can take steps to prevent low iron saturation levels.
For example, they can eat plenty of iron-rich foods, which include:
They can also follow a diet that promotes the absorption of iron in the blood. While vitamin C may increase the bioavailability of iron, experts believe that calcium decreases it.
A person with known risk factors for low iron saturation can reduce their risk by regularly screening for iron deficiency anemia.
Parents and caregivers can help prevent low iron saturation in infants by ensuring that they meet their daily recommended iron intake.
According to the National Institutes of Health (NIH), the recommended iron dietary iron intake is:
Iron-fortified formula can also help a child meet their iron needs. Once a child begins eating solid food, it is important to introduce foods that contain iron.
Iron saturation refers to the amount of iron that is present in the blood. Low iron saturation means that there is a low amount of iron in the blood. Transferrin binds to and transports iron, while ferritin stores this mineral in the body.
Low iron saturation has a range of possible causes, including pregnancy, frequent bleeding, heavy menstruation, and certain genetic or gastrointestinal disorders. A medical professional will diagnose low iron saturation using a combination of tests, which may include a complete blood count, a serum iron test, a transferrin test, and a TIBC test.
The treatment for low iron saturation typically includes a diet rich in iron, iron supplements, and medicinal iron.
Chronic iron deficiency may lead to complications such as heart problems, infections, and developmental delays.
A person can often prevent low iron saturation by following a diet rich in iron to ensure that they meet the recommended daily iron intake.
See the article here:
Low iron saturation: Symptoms, treatment, and more - Medical News Today
- Adult Stem Cells: What They Are and What They Do - February 6th, 2025
- What Are Adult Stem Cells and Are They Right for You? - February 6th, 2025
- Stem Cell Program | Adult Stem Cells - Boston Children's Hospital - February 6th, 2025
- Different Types Of Stem Cells: Embryonic Vs. Adult ... - January 17th, 2025
- Rejuvenation of Aging Adult Stem Cells to Improve their Regenerative Potential - Frontiers - January 13th, 2025
- Hope Biosciences Research Foundation Authorized to Begin Phase II Clinical Trial in Stem Cell Therapy for Juvenile Idiopathic Arthritis - Business... - December 22nd, 2024
- What Are Stem Cells? Biomedical Beat Blog National Institute of ... - November 29th, 2024
- TVHS opens stem cell processing lab to expand biotherapies | VA Tennessee Valley health care | Veterans Affairs - Veterans Affairs - November 8th, 2024
- Understanding Mature Tissue or Organ Stem Cells and Their Clinical ... - November 8th, 2024
- Biology of stem cells: an overview - PMC - PubMed Central (PMC) - October 30th, 2024
- New government tech deals boost the business of cancer detection - GOV.UK - October 11th, 2024
- Stem cell therapy reverses type 1 diabetes in world first - Yahoo News UK - October 11th, 2024
- Advances in different adult stem cell-derived exosomal non-coding RNAs for the treatment of neurological disorders: a narrative review - Frontiers - September 26th, 2024
- Breakthrough technique may help speed understanding, treatment of MD, ALS - Harvard Gazette - September 14th, 2024
- Rostock University Explores Use of Stem Cells for Meat Cultivation with Help from Innocent Meat - vegconomist - the vegan business magazine - August 12th, 2024
- Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - July 31st, 2024
- Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024 - July 31st, 2024
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - July 31st, 2024
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024 - July 31st, 2024
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 - July 31st, 2024
- Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7 - July 31st, 2024
- Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency... - July 31st, 2024
- Targeting the stem cell niche micro-environment as therapeutic strategies in aging - Frontiers - June 28th, 2024
- International trial introduces another curative option for sickle cell disease - EurekAlert - June 28th, 2024
- HOX genes in stem cells: Maintaining cellular identity and regulation of differentiation - Frontiers - June 28th, 2024
- Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - June 21st, 2024
- Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and... - June 21st, 2024
- Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management - June 21st, 2024
- Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC. - June 21st, 2024
- Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Samer Kaba, MD as Chief Medical Officer - June 21st, 2024
- API and the University of Alberta Break Ground in Edmonton on Canada’s Largest Manufacturing Facility for Critical Medicines - June 21st, 2024
- Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems - June 21st, 2024
- Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform - June 21st, 2024
- Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog... - June 21st, 2024
- Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting - June 21st, 2024
- Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing - June 21st, 2024
- NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - June 21st, 2024
- Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran - June 21st, 2024
- Idorsia’s novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the ‘Primary & Speciality’... - June 21st, 2024
- Radiopharm Receives Strategic Investment for up to A$18 million - June 21st, 2024
- Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee - June 21st, 2024
- Trading by management and close relations of management - June 21st, 2024
- Major shareholder announcement - June 21st, 2024
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - June 21st, 2024
- Nature retracts highly cited 2002 paper that claimed adult stem cells could become any type of cell - Retraction Watch - June 19th, 2024
- Shares of Biotech MicroCap Rip on Licensing Talks - The Globe and Mail - June 15th, 2024
- Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024 - May 23rd, 2024
- Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 23rd, 2024
- Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist... - May 23rd, 2024
- Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus... - May 23rd, 2024
- Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024 - May 23rd, 2024
- New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing Capabilities at the Grand Opening of... - May 23rd, 2024
- Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients - May 23rd, 2024
- Kane Biotech Announces First Quarter 2024 Financial Results - May 23rd, 2024
- Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast - May 23rd, 2024
- Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy - May 23rd, 2024
- Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 - May 23rd, 2024
- 23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results - May 23rd, 2024
- Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 23rd, 2024
- Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting - May 23rd, 2024
- Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024 - May 23rd, 2024
- Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences - May 23rd, 2024
- NANOBIOTIX to Present at the Jefferies Global Healthcare Conference - May 23rd, 2024
- Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - May 23rd, 2024
- Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual... - May 23rd, 2024
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
Recent Comments